Advertisement
Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 0.7318 |
| Open | 0.7450 |
| Bid | 0.7354 x 900 |
| Ask | 0.7974 x 900 |
| Day's Range | 0.7213 - 0.7810 |
| 52 Week Range | 0.5400 - 2.0500 |
| Volume | |
| Avg. Volume | 3,945,479 |
| Market Cap | 131.229M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4000 |
| Earnings Date | Nov 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.87 |
GlobeNewswireSeres Therapeutics to Participate in Piper Sandler Healthcare Conference
CAMBRIDGE, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that Eric Shaff, President and Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024, at 4:30 p.m. ET. A live webcast of the chat will be accessible through the “Events and Presentations” tab on the “Investors and News” section of the Company’s website at www.seresther
Simply Wall St.Seres Therapeutics Third Quarter 2024 Earnings: US$0.33 loss per share (vs US$0.37 loss in 3Q 2023)
Seres Therapeutics ( NASDAQ:MCRB ) Third Quarter 2024 Results Key Financial Results Net loss: US$51.0m (loss widened by...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.